Skip to main content
. 2022 May 3;327(17):1656–1665. doi: 10.1001/jama.2022.4712

Table 1. Baseline Characteristics of Patients in the BUMP 1 Clinical Trial, by Randomized Group.

Characteristic No./total (%)
Self-monitoring group (n = 1220)a Usual care group (n = 1217)a
Age, mean (SD), y 32.8 (5.7) 33.0 (5.6)
Gestation at entry, mean (SD), wk 20.3 (1.6) 20.3 (1.6)
Parity: no previous births 745 (61.1) 742 (61.0)
BMI, median (IQR)b 26.5 (22.7-32.1) 26.1 (22.6-32.4)
Index of multiple deprivation quintilec
No. 1210 1211
1 (most deprived) 167 (13.8) 170 (14.0)
2 247 (20.4) 239 (19.7)
3 228 (18.8) 258 (21.3)
4 254 (21.0) 244 (20.2)
5 (least deprived) 314 (26.0) 300 (24.8)
Race and ethnicityd
No. 1211 1007
Asian or Asian British 135 (11.1) 118 (9.8)
Black or Black British 88 (7.3) 99 (8.2)
Chinese 16 (1.3) 11 (0.9)
Mixed 55 (4.5) 41 (3.4)
White (British, Irish, other) 887 (73.3) 914 (75.7)
Other 30 (2.5) 24 (2.0)
Current smoker 57 (4.7) 59 (4.9)
Highest education
No. 1209 1201
Tertiary education 715 (59.1) 684 (57.0)
Professional qualifications 122 (10.1) 120 (10.0)
A-level or General Certificate of Secondary Education 294 (24.3) 335 (27.9)
Vocational qualifications 34 (2.8) 32 (2.7)
No formal qualifications 44 (3.6) 30 (2.5)
Risk factors for hypertension
BMI ≥30 444 (46.4) 417 (34.3)
Previous hypertensive disorder of pregnancy 199 (16.3) 220 (18.1)
Family history of preeclampsia 144 (11.8) 133 (10.9)
Autoimmune diseasee 83 (6.8) 81 (6.7)
Prepregnancy diabetes (type 1 or 2) 75 (6.2) 67 (5.5)
Twin pregnancy 73 (6.0) 67 (5.5)
Interval between pregnancies >10 y 34 (2.8) 36 (3.0)
Chronic kidney disease (any grade) 9 (0.7) 14 (1.2)
Blood pressure, mean (SD), mm Hgf
No. 1161 1162
Systolic BP at entry 113.4 (12.8) 113.9 (12.3)
Diastolic BP at entry 68.5 (9.0) 69.0 (9.0)
Health questionnaires
EQ-5D-5L index valueg
No. 1202 1194
Median (IQR) 0.88 (0.77-1.00) 0.85 (0.77-1.00)
STAI-6h
No. 1201 1191
Median (IQR) 22.2 (5.6-33.3) 22.2 (5.6-33.3)
Self-monitoring prior to trial
No. 1209 1205
No. (%) 305 (25) 334 (28)

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); BP, blood pressure.

a

As shown in the Figure, 1223 (self-monitoring) and 1218 (control) were randomized; however, 3 intervention participants and 1 usual care participant were randomized in error and withdrawn immediately. Therefore, data are presented for the remaining 1220 and 1217.

b

Calculated as weight in kilograms divided by height in meters squared.

c

The index of multiple deprivation is an assessment of deprivation based on multiple weighted components including income, employment, education, health, crime, barriers to housing and services, and living environment. It is assessed at the postcode level.

d

Ethnicity and race self-attributed from closed list based on standard UK classification. Mixed included those self-identifying as mixed ethnicity (any combination). “Other” included any other category not listed, in which case participants were asked to specify (in the self-monitoring group: Arab: 4, Japanese: 3, Latin American: 2, Mauritian: 2, Brazilian: 1, Filipino: 1, Iraqi Kurdish: 1, Pacific Islander: 1, Tibetan Burmese Origin: 1, Turkish Kurdish: 1, Vietnamese: 1, Middle Eastern: 1, none stated: 11. Usual care group: Latin American: 6, Arab: 3, Japanese: 2, Afghan: 1, Brazilian: 1, Filipino: 1, Iranian: 1, Malaysian: 1, South East Asia: 1, South Korean: 1, Vietnamese: 1, none stated: 5).

e

Any autoimmune disease, eg, systemic lupus erythematosus or antiphospholipid syndrome.

f

At last clinic visit prior to randomization.

g

EQ-5D-5L: EuroQol instrument 5 Dimensions 5 Levels (index value calculated from 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Value calculated using cross-walk tool22 range, −0.3-1; higher is better quality of life).

h

STAI: short form of State-Trait Anxiety Inventory (6 items; range, 6-24; scaled to be out of 100, higher is more anxious).20